BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Harvard Global Health Institute - ECPv6.5.1.4//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Harvard Global Health Institute
X-ORIGINAL-URL:https://globalhealth.harvard.edu
X-WR-CALDESC:Events for Harvard Global Health Institute
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20240101T000000
END:STANDARD
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20240310T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20241103T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20250309T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20251102T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20250328T080000
DTEND;TZID=UTC:20250328T084500
DTSTAMP:20260818T125616
CREATED:20250318T170952Z
LAST-MODIFIED:20250318T171040Z
UID:10000836-1743148800-1743151500@globalhealth.harvard.edu
SUMMARY:StITCH: Transforming Hepatitis Care Through Shared Partnership and Leadership
DESCRIPTION:In this dynamic three-way dialogue\, representatives from Harvard Medical School Program in Global Primary Health Care\, the University of the Philippines Manila\, and the Yellow Warriors Society of the Philippines (YWSP) share the story of StITCH\, a multi-sectoral partnership to deliver primary health care for people living with hepatitis\, rooted in person-centeredness\, shared leadership\, and community empowerment. Through an evolving collaboration\, StITCH has demonstrated how research\, project implementation\, and advocacy can be co-created with the very people most affected and provide benefits for all involved. More than a project\, it is a sustained effort to shift power\, build trust\, and embed meaningful engagement within the health system. As we reflect on its creation\, impact\, and future\, we invite you to see what’s possible when academia\, healthcare providers\, and people with lived experience come together—not just to improve hepatitis care\, but to transform how partnerships in health are built and sustained. \nThis event is free and open to the public.  \nRegister \n  \nAbout the Speakers\n \nBeth Holt\, MD\, MPH  \nAssociate Director of Health Systems\, Global Primary Health Care  \nDr. Beth Holt\, MD\, MPH is the Global Primary Health Care Associate Director of Health Systems at the HMS Center for Primary Care. Within the program she currently leads the co-design and implementation of Strengthening the Integrated Treatment and Care of Hepatitis (STITCH)\, a primary care system strengthening program to design and scale up a new person-centered model of care within Vietnam and the Philippines from 2022 to 2026. With over 7 years in the health and social impact sectors\, she brings a multi-disciplinary perspective as an Australian-trained medical doctor\, applying her experience as a clinician\, researcher\, and consultant in the U.S. and Asia-Pacific to reduce health disparities. Dr. Holt’s academic focus is on strengthening health systems through implementation science\, community partnership\, and participatory research. \n  \n \nJhaki Mendoza\, MA \nUniversity of the Philippines  \nJhaki Mendoza\, MA is a medical anthropologist specializing in chronic conditions and people-centered healthcare. She has led the Patient Journey Mapping research component of StITCH Philippines\, with recent research co-produced alongside the Yellow Warriors Society Philippines. Jhaki has worked on mixed-method studies exploring the lived experiences of individuals with chronic illnesses such as hypertension and diabetes\, collaborating with the London School of Hygiene and Tropical Medicine\, UCSI University in Malaysia and Duke University in China. She has also been involved in works related to early childhood care development\, nutrition and food security. She holds a BA in Anthropology from the University of the Philippines Diliman and an MA in Medical Anthropology from the University of the Philippines Manila. Her research integrates qualitative and participatory approaches to improve health systems\, particularly for socio-economically disadvantaged communities. \n  \n \nDiana Rose De Silva \nAuditor of Yellow Warrior Society Philippines  \nDiana Rose De Silva is a patient advocate and researcher based in Sampaloc\, Manila\, Philippines. She holds a Bachelor of Science in Information Technology from the International Electronics and Technical Institute\, Alabang Campus Metro Manila\, Philippines. Since 2019\, Diana has been a national officer and advocate for the Yellow Warriors Society Philippines\, a patient support and advocacy group for Filipinos living with hepatitis B and C. Diana also serves as one of the patient leaders for the Philippine Alliance of Patient Organizations\, a national coalition of patient support groups in the Philippines. She has represented the voice of people with lived experience at international forums\, including the 77th World Health Assembly in Geneva\, Switzerland\, and the APAC Liver Disease Alliance Summit in Bangkok\, Thailand. Currently\, she works as a part-time research assistant at the StITCH project\, contributing to the development of a patient-centered primary care strengthening model for hepatitis in the Philippines. \n  \nAbout the Global Health Coffee Sessions Event Series\nThe HGHI Coffee Sessions Virtual Series takes place on the last Friday of each month from 9:00 AM – 9:45 AM Eastern Time. Showcasing global health researchers and practitioners from Harvard and beyond\, this series aims to explore the role of partnership and collaboration when working to advance global health equity. A diverse range of topics will be covered; including climate change and health\, global health security\, mental healthcare\, reproductive healthcare access\, financing and governance for global health\, healthcare in conflict areas\, digital health\, and more. This series will take place online over Zoom\, and all sessions will be recorded and available on our YouTube Channel. \nThrough our events and programs\, the Harvard Global Health Institute provides a platform for different perspectives and debates within the field of global health through a variety of media. The views expressed in these events and programs are solely those of the speakers\, authors\, researchers\, and participating audience. As such\, they do not speak for the Institute or the university.
URL:https://globalhealth.harvard.edu/event/global-health-coffee-sessions-stitch/
LOCATION:Virtual
CATEGORIES:Virtual
ATTACH;FMTTYPE=image/png:https://globalhealth.harvard.edu/wp-content/uploads/2024/10/3-28-2025-Coffee-Sessions-Promo-Image-900x600px.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20250311T120000
DTEND;TZID=America/Halifax:20250311T124500
DTSTAMP:20260818T125616
CREATED:20250211T212100Z
LAST-MODIFIED:20250212T214938Z
UID:10000275-1741694400-1741697100@globalhealth.harvard.edu
SUMMARY:Innovation to Transform Underperforming Health Systems
DESCRIPTION:  \nHealth systems worldwide face multiple and converging challenges: epidemiological transition leading to rising burden of disease and disability\, rising demand for health services\, higher societal expectations\, increasing health expenditures\, slow economic growth and fiscal conservatism with austerity policies that constrain investment in health systems. Innovation is critical for fundamental transformation of health systems to overcome these challenges\, build responsiveness and resilience\, and ensure sustainability. This session will present an analysis of health systems responses to evolving challenges and identify areas of major underperformance. It will explore emerging innovations that could be harnessed to transform health systems to improve population health outcomes and societal wellbeing. \nThis event is free and open to the public.  \nRegister \n  \nAbout the Speaker\n \nRifat Atun\, MBBS\, MBA\, FFPH\, FRCGP\, FRCP \nProfessor of Global Health Systems in the Department of Global Health and Population at Harvard T.H. Chan School of Public Health \nRifat Atun is Professor of Global Health Systems at Harvard University and the Director of The Health System Innovation Lab. In 2015-2023 he was the Faculty Chair for the Harvard Ministerial Leadership Program. He is a Faculty Affiliate at the Center for International Development at the Harvard Kennedy School\, and Faculty and Member of the Harvard University Asia Center Steering Committee and Council. Professor Atun is a Visiting Professor at Imperial College London\, and a Distinguished Visiting Professor at Fukushima University in Japan. \nProfessor Atun has published more than 450 papers in leading journals including the Lancet\, NEJM\, Nature Medicine\, Academy of Management Journal\, Lancet Global Health\, Lancet Infectious Diseases\, Lancet Oncology\, and Lancet Psychiatry. In 2020\, 2021\, 2022\, 2023\, and 2024 he was recognized by the Web of Science/Clarivate as one of the World’s Highly Cited Researchers. \nProfessor Atun has worked with more than 30 governments globally and with the World Bank\, World Health Organization\, and the UK Department for International Development (DfID) to design\, implement and evaluate health system reform initiatives. In 1999-2006 he was a member of the UK DfID Resource Centre for Health Systems. Professor Atun has led executive education programs and undertaken assignments for major organizations including Novartis\, Medtronic\, GSK\, Pfizer Inc.\, the Vodafone Group\, and Hofmann-La Roche. \n  \nAbout the Global Research and Innovation Speaker Series\nThe Harvard Global Health Institute’s Global Health Research and Innovation Speaker Series showcases the latest scholarly and scientific advancements in global health across Harvard and beyond\, to make cutting-edge research accessible to a diverse global audience\, and to spark innovative solutions in the pursuit of health equity and improved health outcomes worldwide. The public series takes place virtually on the second Tuesday of each month from 12:00 to 12:45 pm ET. Each session will include a presentation by a featured speaker showcasing their innovative research in global health\, followed by a moderated Q&A. \nSpeakers will share their own perspectives; they do not speak for Harvard.
URL:https://globalhealth.harvard.edu/event/research-and-innovation-rifat-atun/
LOCATION:Virtual
CATEGORIES:Virtual
ATTACH;FMTTYPE=image/png:https://globalhealth.harvard.edu/wp-content/uploads/2024/05/Eram-Alam-Social-Post-1-4.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20250228T090000
DTEND;TZID=UTC:20250228T094500
DTSTAMP:20260818T125616
CREATED:20250219T193331Z
LAST-MODIFIED:20250221T150409Z
UID:10000835-1740733200-1740735900@globalhealth.harvard.edu
SUMMARY:Centering Equity and Impact in Global North-South Research Partnerships
DESCRIPTION:Equitable research partnerships require intentionality\, shared decision-making\, and a commitment to long-term impact. This session will bring together leading voices in global health research\, Bethany Hedt-Gauthier\, PhD\, Associate Professor in the Department of Global Health and Social Medicine at Harvard Medical School and Vincent Cubaka\, MD\, MMed (FM)\, PhD\, Head of Knowledge and Social Medicine Division at Partners In Health\, to discuss their global research partnership\, touching upon extractive research and exploring what their work looks like on the ground with best practices in decision-making\, equity\, and maintaining community relevance. The session will examine the development of their mobile health platform that uses AI and community health workers to detect infection in Cesarean section wounds to exemplify these principles in action. Attendees will learn actionable strategies on how academic institutions\, individual researchers\, and NGO partners can move forward to foster effective global health collaborations. \nAbout the Speaker\n \nDr. Bethany Hedt-Gauthier\, PhD \nAssociate Professor in the Department of Global Health and Social Medicine at Harvard Medical School \nDr. Bethany Hedt-Gauthier is a biostatistician specializing in health systems and implementation science research in sub-Saharan Africa. Dr. Hedt-Gauthier received a BS with distinction in mathematics from the University of North Carolina-Chapel Hill and her PhD in Biostatistics from Harvard. She is an Associate Professor in Global Health and Social Medicine at Harvard Medical School and has led global surgery and digital health research in Rwanda for the last 10 years. Dr. Hedt-Gauthier is committed to improving partnerships in global health research\, by innovating within her own practice and by leading research and advocacy on issues of power dynamics and inequitable research collaborations. \n\n \nDr. Vincent K. Cubaka MD\, MMed (FM)\, PhD \nHead of Knowledge and Social Medicine Division\, Partners in Health \nDr. Vincent K. Cubaka is a medical doctor\, health systems researcher\, and educator with a wealth of experience in various healthcare capacities. Beginning his career as a rural clinician\, he transitioned into academia\, where he served as both a lecturer and researcher. Eventually\, Dr. Cubaka assumed the leadership role of Head of the Department of Primary Health Care at the University of Rwanda (UR). In 2019\, he embarked on a new phase of his career by joining Partners in Health (PIH/IMB) as Director of Research and Training. Most recently\, he has taken on the important role of Head of Knowledge and Social Medicine Division within the organization. Dr. Cubaka’s academic qualifications include a Master of Medicine in Family and Community Medicine from UR\, as well as a Doctorate in Medicine from Aarhus University in Denmark. \n  \nAbout the Global Health Coffee Sessions Event Series\nThe HGHI Coffee Sessions Virtual Series takes place on the last Friday of each month from 9:00 AM – 9:45 AM Eastern Time. Showcasing global health researchers and practitioners from Harvard and beyond\, this series aims to explore the role of partnership and collaboration when working to advance global health equity. A diverse range of topics will be covered; including climate change and health\, global health security\, mental healthcare\, reproductive healthcare access\, financing and governance for global health\, healthcare in conflict areas\, digital health\, and more. This series will take place online over Zoom\, and all sessions will be recorded and available on our YouTube Channel. \nThrough our events and programs\, the Harvard Global Health Institute provides a platform for different perspectives and debates within the field of global health through a variety of media. The views expressed in these events and programs are solely those of the speakers\, authors\, researchers\, and participating audience. As such\, they do not speak for the Institute or the university.
URL:https://globalhealth.harvard.edu/event/global-health-coffee-sessions-2-2/
LOCATION:Virtual
CATEGORIES:Virtual
ATTACH;FMTTYPE=image/png:https://globalhealth.harvard.edu/wp-content/uploads/2024/10/2-28-2025-Coffee-Sessions-1920x1080px.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20250211T100000
DTEND;TZID=America/Halifax:20250211T104500
DTSTAMP:20260818T125616
CREATED:20250114T171553Z
LAST-MODIFIED:20250122T144542Z
UID:10000271-1739268000-1739270700@globalhealth.harvard.edu
SUMMARY:The History and Challenges of Immigrant Physicians in the US Healthcare System
DESCRIPTION:  \nSince the 1960s\, the United States has relied on soliciting immigrant physicians to fill vacancies due to the shortage of U.S.-trained doctors. In this talk\, Professor Eram Alam will examine the reasons behind this physician migration and how this migratory flow continues to influence US healthcare dynamics. The widespread and essential presence of foreign physicians in the U.S. highlights not only the racial dynamics within the US healthcare system but also illustrates the broader workings of the political economy of healthcare in our globalized era. \nThis event is free and open to the public.  \nRegister \n  \nAbout the Speaker\n \nEram Alam\, PhD\, Assistant Professor of the History of Science\, Harvard University \nEram Alam is an Assistant Professor of the History of Science at Harvard University. Her research is primarily concerned with the history of medicine\, with a particular emphasis on globalization\, race\, migration\, and health during the twentieth century. Her first book\, The Care of Foreigners: How Immigrant Physicians Changed US Healthcare\, explores the enduring consequences of post-colonial physician migration from Asia to the United States since 1965. Her next project\, Patients Without Borders\, is also inspired by mobility regimes and traces US patient movement to sites outside of the country for medical care. As access to routine care such as hip replacements or dental services becomes more convoluted and fragmented\, the project asks: how have medical travel patterns and routes to certain countries emerged and stabilized? \n  \n  \n  \nAbout the Moderator\n \nDavid S. Jones\, MD\, PhD\, A. Bernard Ackerman Professor of the Culture of Medicine at Harvard Medical School and in the History of Science at Harvard Faculty of Arts and Sciences; Professor of Epidemiology at the Harvard T.H. Chan School of Public Health \nTrained in psychiatry and history of science\, David Jones is the Ackerman Professor of the Culture of Medicine at Harvard University. His research has focused on the causes and meanings of health inequalities (Rationalizing Epidemics: Meanings and Uses of American Indian Mortality since 1600) and the history of decision making in cardiac therapeutics (Broken Hearts: The Tangled History of Cardiac Care). He is currently at work on four other histories\, of the evolution of coronary artery surgery\, of heart disease and cardiac therapeutics in India\, of the threat of air pollution to health in India\, and of the history of air pollution research in the United States. His teaching at Harvard College and Harvard Medical School explores the history of medicine\, medical ethics\, and social medicine. \n  \n  \n  \nAbout the Global Health Research & Innovation Speaker Series\nThe Harvard Global Health Institute’s Global Health Research and Innovation Speaker Series showcases the latest scholarly and scientific advancements in global health across Harvard and beyond\, to make cutting-edge research accessible to a diverse global audience\, and to spark innovative solutions in the pursuit of health equity and improved health outcomes worldwide. The public series takes place virtually on the second Tuesday of each month from 12:00 to 12:45 pm ET. Each session will include a presentation by a featured speaker showcasing their innovative research in global health\, followed by a moderated Q&A. \nSpeakers will share their own perspectives; they do not speak for Harvard.
URL:https://globalhealth.harvard.edu/event/alam-research-innovation/
LOCATION:Virtual
CATEGORIES:Virtual
ATTACH;FMTTYPE=image/png:https://globalhealth.harvard.edu/wp-content/uploads/2025/01/Alam-Speaker-Series-Banner-2.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20250124T090000
DTEND;TZID=UTC:20250124T094500
DTSTAMP:20260818T125616
CREATED:20241028T145156Z
LAST-MODIFIED:20250110T154657Z
UID:10000832-1737709200-1737711900@globalhealth.harvard.edu
SUMMARY:Employing Digital Tools and Technology to Expand Access to Healthcare
DESCRIPTION:Technology has the potential to revolutionize global health by improving access to care\, enhancing service quality\, and reducing costs. Telehealth\, mobile health apps\, and data analytics are some of the tools being used to improve access to care and bridge disparities. Join us for an insightful session with Dr. Jarone Lee\, MD\, MPH and Dr. Eva Regel\, DBE\, MBE\, MS\, of Health Tech Without Borders to dive deeper into this topic and discuss their work and the effective outcomes of their partnership. Attendees will gain insights into successful strategies and challenges in the various regions where Health Tech Without Borders works\, emphasizing the importance of local context\, cultural sensitivity\, and collaboration.  \nThis event is free and open to the public.  \nRegister \n\nAbout the Speakers\n  \n \nJarone Lee\, MD\, MPH\, Co-Founder\, Health Tech Without Borders\, Associate Professor of Emergency Medicine  \nDr. Jarone Lee\, MD\, MPH is a dual-trained specialist in emergency and critical care medicine\, with over a decade of experience as a disaster responder. He co-founded Health Tech Without Borders\, Inc. (HTWB)\, a global non-profit dedicated to using digital tools and technology to provide immediate access to health resources in humanitarian crises. Dr. Lee is an Associate Professor at Harvard Medical School and serves as Director of Global Partnerships at MGB Global Advisory. Additionally\, Dr. Lee leads critical care strategy as Vice Chief of Critical Care in the Division of Trauma\, Emergency Surgery\, and Surgical Critical Care at Massachusetts General Hospital. Dr. Lee graduated from Mount Sinai School of Medicine and completed his residency training at St. Luke’s Roosevelt of Columbia University before completing a fellowship in Critical Care at Mass General Hospital.  \n  \n Eva Regel\, DBE\, MBE\, MS\, Clinical Director\, Health Tech Without Borders\, Assistant Professor of Medical Humanities and Bioethics\, Clinical ethicist at the University of Arkansas for Medical Sciences \nDr. Eva Regel\, DBE\, MBE\, MS is an Assistant Professor at the Department of Medical Humanities and Bioethics and clinical ethicist at the University of Arkansas for Medical Sciences in Little Rock\, Arkansas. She is also a clinical director at Health Tech Without Borders\, where she leads Helping Healers Heal\, a program aimed at mental health peer-to-peer support of healthcare providers and mental health clinicians working in zones of humanitarian disaster. She performs ethics consultations for adult patients\, their families\, and health care teams\, conducts research\, writes on issues in clinical ethics\, and leads and participates in medical staff debriefings\, support\, and education. Dr. Regel’s research interests include humanitarian ethics\, specifically areas of research in moral distress and moral injury in first responders working in disaster and war regions. She also has extensive clinical skills and expertise in mental health\, including crisis interventions\, trauma counseling (both physical trauma and psychosocial trauma\, including childhood trauma)\, counseling on acute and post-traumatic stress\, death and dying\, adjustment to illness\, anxiety\, and depression.   \nDr. Regel received her doctoral degree in Bioethics at Loyola University Chicago\, master’s degree in Bioethics from Harvard Medical School\, master’s degree in clinical social work from Boston College\, master’s degree in economics from Houston University\, and bachelor’s degree in Biophysics from Moscow State University.     \n  \nAbout the Global Health Coffee Sessions Event Series\nThe HGHI Coffee Sessions Virtual Series takes place on the last Friday of each month from 9:00 AM – 9:45 AM Eastern Time. Showcasing global health researchers and practitioners from Harvard and beyond\, this series aims to explore the role of partnership and collaboration when working to advance global health equity. A diverse range of topics will be covered; including climate change and health\, global health security\, mental healthcare\, reproductive healthcare access\, financing and governance for global health\, healthcare in conflict areas\, digital health\, and more. This series will take place online over Zoom\, and all sessions will be recorded and available on our YouTube Channel. \nThrough our events and programs\, the Harvard Global Health Institute provides a platform for different perspectives and debates within the field of global health through a variety of media. The views expressed in these events and programs are solely those of the speakers\, authors\, researchers\, and participating audience. As such\, they do not speak for the Institute or the university.
URL:https://globalhealth.harvard.edu/event/employing-digital-tools-and-technology-to-expand-access-to-healthcare/
LOCATION:Virtual
CATEGORIES:Virtual
ATTACH;FMTTYPE=image/png:https://globalhealth.harvard.edu/wp-content/uploads/2024/10/1-24-2025-Coffee-Sessions-Promo-Image-900x600px-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20241213T090000
DTEND;TZID=UTC:20241213T094500
DTSTAMP:20260818T125616
CREATED:20241122T191500Z
LAST-MODIFIED:20241126T205052Z
UID:10000962-1734080400-1734083100@globalhealth.harvard.edu
SUMMARY:A Partnership to Catalyze Hepatitis Elimination in the Philippines and Strengthen Primary Healthcare
DESCRIPTION:Viral hepatitis stands as a formidable global health challenge and a leading cause of preventable deaths. In this session\, we will learn about the ongoing efforts to mitigate this pressing issue and how hepatitis care has been used as a strategic entry point to fortify primary healthcare systems. Dr. David B. Duong\, MD\, MPH\, Dr. Janus P. Ong\, MD\, MPH and Dr. Todd Pollack\, MD will join us to discuss their collaboration spanning the United States\, Vietnam\, and the Philippines\, where they navigate diverse political\, social\, and health system landscapes to advance a unified goal of equitable\, people-centered care. By fostering local ownership and ensuring solutions are culturally and contextually appropriate\, the partnership exemplifies how global cooperation can drive scalable and sustainable healthcare innovations. Dr. Louise C. Ivers will moderate the session. \nThis event is free and open to the public. \nRegister \n\nAbout the Speakers\n  \n \nDavid B. Duong\, MD\, MPH\, Director\, Global Primary Health Care\, Harvard Medical School \nDr. David Duong\, MD\, MPH is the Director of Global Primary Health Care at the Harvard Medical School Center for Primary Care and in the Division of Global Health Equity at the Brigham and Women’s Hospital. Dr. Duong is responsible for the overall strategy development\, partnership engagement\, programmatic activities and donor relations for Global Primary Health Care to meet the goals and mission of Harvard Medical School as well as the local\, national and global primary health care community. His work covers primary healthcare training\, systems strengthening\, co-design\, policy and advocacy across Southeast Asia and in the United States. He has led many research studies and has published on health care systems\, including co-leading the Lancet Global Health Commission on People-Centered Care for Universal Health Coverage.  Dr. Duong is a primary care physician\, a member of the World Health Organization’s Technical Advisory Group on Integrated Clinical Care\, and previously served on the World Economic Forum’s Global Future Council on Health and Healthcare. \n  \n \nJanus P. Ong\, MD\, MPH\, Assistant to the Vice Chancellor for Research\, University of the Philippines Manila; Project Leader\, StITCH Philippines \nDr. Janus Ong is a gastroenterologist and transplant hepatologist\, researcher\, and hepatitis advocate. He is head of the Liver Research Program at the University of the Philippines-National Institutes of Health (NIH) and serves as Assistant to the Vice Chancellor for Research at the University of the Philippines Manila. He is an active consultant in gastroenterology and transplant hepatology at The Medical City and the Philippine General Hospital. He has published more than 70 research articles across his areas of interest in MASLD\, hepatocellular carcinoma\, hepatitis B and C\, complications of cirrhosis\, and public health. He is on the editorial board of Alimentary\, Pharmacology & Therapeutics and World Journal of Hepatology. He works with the Department of Health\, World Health Organization\, Yellow Warriors Society of the Philippines\, and various professional societies on hepatitis awareness campaigns and various projects to contribute to hepatitis prevention and control in the Philippines. \n  \n \nTodd Pollack\, MD\, Director\, Implementation Science\, Global Primary Health Care\, Harvard Medical School \nDr. Todd Pollack is the Director of Implementation Science for Global Primary Health Care at the Harvard Medical School Center for Primary Care. He is an infectious disease clinician at Beth Israel Deaconess Medical Center\, Assistant Professor of Medicine at Harvard Medical School\, and the Medical Director of the Partnership for Health Advancement in Vietnam (HAIVN)\, a Harvard University Global Program with a mission to improve healthcare in Vietnam. His work focuses on strengthening primary healthcare systems in low- and middle-income countries and on improving access to quality and equitable care for people living with HIV and viral hepatitis. Dr. Pollack leads clinical training\, capacity building\, and health system strengthening projects in Vietnam and other Southeast Asian countries and he co-leads the Lancet Global Health Commission on People-Centered Care for Universal Health Coverage. \n  \nAbout the Moderator\n \nLouise C. Ivers\, MD\, MPH\, DTM&H\, Faculty Director\, Harvard Global Health Institute \nDr. Louise C. Ivers\, MD\, MPH\, DTM&H is the Faculty Director of the Harvard Global Health Institute and the Executive Director of the Massachusetts General Hospital (MGH) Center for Global Health. Dr. Ivers is also the David Bangsberg Endowed Chair in Global Health Equity at MGH and a Professor of Medicine and Professor of Global Health and Social Medicine at Harvard Medical School. Dr. Ivers has spent her career providing care to the rural and urban poor and engaging in patient-oriented investigation that offer solutions to barriers to healthcare. She works on the design\, implementation\, and evaluation of large-scale public health programs in resource-limited settings with the goal of achieving health equity. She has worked on healthcare delivery in India\, Southeast Asia\, and Africa. From 2003-2017\, Dr. Ivers served in various leadership roles for Partners in Health\, including Clinical Director\, Chief of mission\, and Director of strategic implementation. In addition to expanding access to healthcare for the poor\, Dr. Ivers has contributed to published research articles on HIV/AIDS\, food insecurity\, and cholera treatment and prevention and is involved in global policy and advocacy. \n  \nAbout the Global Health Coffee Sessions Event Series\nThe HGHI Coffee Sessions Virtual Series takes place on the last Friday of each month from 9:00 AM – 9:45 AM Eastern Time. Showcasing global health researchers and practitioners from Harvard and beyond\, this series aims to explore the role of partnership and collaboration when working to advance global health equity. A diverse range of topics will be covered; including climate change and health\, global health security\, mental healthcare\, reproductive healthcare access\, financing and governance for global health\, healthcare in conflict areas\, digital health\, and more. This series will take place online over Zoom\, and all sessions will be recorded and available on our YouTube Channel. \nThrough our events and programs\, the Harvard Global Health Institute provides a platform for different perspectives and debates within the field of global health through a variety of media. The views expressed in these events and programs are solely those of the speakers\, authors\, researchers\, and participating audience. As such\, they do not speak for the Institute or the university.
URL:https://globalhealth.harvard.edu/event/a-partnership-to-catalyze-hepatitis-elimination-in-the-philippines-and-strengthen-primary-healthcare/
LOCATION:Virtual
CATEGORIES:Virtual
ATTACH;FMTTYPE=image/png:https://globalhealth.harvard.edu/wp-content/uploads/2024/11/12-13-24-Coffee-Sessions-Promo-Image-900x600px.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20241210T120000
DTEND;TZID=America/Halifax:20241210T124500
DTSTAMP:20260818T125616
CREATED:20241126T204735Z
LAST-MODIFIED:20241209T190819Z
UID:10000963-1733832000-1733834700@globalhealth.harvard.edu
SUMMARY:Health System and Reform: China's Experience
DESCRIPTION:In 2009\, China launched a major healthcare reform with the goal to provider universal and equitable access to basic healthcare for its residents. Since then\, China has expanded social insurance coverage to over 96% of its population\, improved access to care and moderately reduced health inequality. However\, the system is confronted with the challenges of rapid cost escalation\, an aging population\, increase non-communicable disease burden and slowed economic growth. \nJoin Professor Winnie Yip\, Professor of Global Health and Economics at the Harvard T.H. Chan School of Public Health and the Faculty Director of the school wide Harvard China Health Partnership\, for a talk about her research on health system reform in China. This seminar analyzes China’s success and challenges in ensuring universal and equitable basic healthcare\, examines strategies for responding to the challenges and draw lessons for other countries in the quest for universal health coverage. Dr. Louise Ivers will moderate the discussion.  \nThe event is free and open to the public. \nAbout the Speakers\n\nWinnie Yip\, Professor of the Practice of Global Health Policy and Economics\, Harvard T.H. Chan School of Public Health \nDr. Winnie Yip is currently Professor of Global Health Policy and Economics at the Harvard T.H. Chan School of Public Health\, and the Faculty Director of the school wide Harvard China Health Partnership. In addition to her academic appointments\, Dr. Yip is a member of the National Committee on US China Relations (NCUSCR) Track II Health Dialogues\, served as the past President of the International Health Economics Association (iHEA)\, and has consulted for numerous international agencies including the World Bank and the World Health Organization. Dr. Yip holds a PhD in Economics from the Massachusetts Institute of Technology. \nHer research focuses on rigorous and policy-relevant health system evaluations and the design and testing of innovative health system interventions to improve equitable access to efficient and good quality health care. She applies this approach to developing viable and effective models of population health based integrated delivery systems in China and India. She is also interested in the implications of China’s ageing population for the country’s health system and in designing and piloting innovative eldercare systems to support older adults in living meaningful lives. Dr. Yip has studied and advised health care reforms in the wider Asia region\, including Hong Kong\, Taiwan\, Thailand\, Malaysia and Vietnam. \n  \n  \n \nLouise C. Ivers\, MD\, MPH\, DTM&H\, Faculty Director\, Harvard Global Health Institute \nDr. Louise C. Ivers\, MD\, MPH\, DTM&H is the Faculty Director of the Harvard Global Health Institute and the Executive Director of the Massachusetts General Hospital (MGH) Center for Global Health. Dr. Ivers is also the David Bangsberg Endowed Chair in Global Health Equity at MGH and a Professor of Medicine and Professor of Global Health and Social Medicine at Harvard Medical School. Dr. Ivers has spent her career providing care to the rural and urban poor and engaging in patient-oriented investigation that offer solutions to barriers to healthcare. She works on the design\, implementation\, and evaluation of large-scale public health programs in resource-limited settings with the goal of achieving health equity. She has worked on healthcare delivery in India\, Southeast Asia\, and Africa. From 2003-2017\, Dr. Ivers served in various leadership roles for Partners in Health\, including Clinical Director\, Chief of mission\, and Director of strategic implementation. In addition to expanding access to healthcare for the poor\, Dr. Ivers has contributed to published research articles on HIV/AIDS\, food insecurity\, and cholera treatment and prevention and is involved in global policy and advocacy.
URL:https://globalhealth.harvard.edu/event/health-system-and-reform-chinas-experience/
LOCATION:Virtual
CATEGORIES:Virtual
ATTACH;FMTTYPE=image/png:https://globalhealth.harvard.edu/wp-content/uploads/2024/11/Professor-Yip-RI-Speaker-Series-Mailchimp-Banner-900-x-600px.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20241112T120000
DTEND;TZID=America/Halifax:20241112T124500
DTSTAMP:20260818T125616
CREATED:20241008T144127Z
LAST-MODIFIED:20241121T220229Z
UID:10000830-1731412800-1731415500@globalhealth.harvard.edu
SUMMARY:Advancing Global Adolescent Health and Nutrition: Insights from the ARISE Network
DESCRIPTION:  \nAdequate nutrition during adolescence can profoundly impact health and well-being in the present\, continuing into adulthood\, and extending to future generations. Evidence from our recent observational and intervention studies demonstrates the effectiveness of integrated approaches in mitigating malnutrition. Dr. Fawzi’s will discuss his research which focuses on addressing pressing health challenges in countries such as Tanzania\, Uganda\, Sudan\, and India. His primary interests include the design and implementation of randomized controlled trials and observational studies targeting maternal\, neonatal\, and child health\, as well as infectious diseases\, with a special emphasis on the role of nutrition. Dr. Louise Ivers will moderate the session. \nThe event is free and open to the public. \nAbout the Speakers\n\nWafaie Fawzi\, MBBS\, MPH\, MS\, DrPH\, Professor of Nutrition\, Epidemiology\, and Global Health at Harvard T.H. Chan School of Public Health \nWafaie Fawzi\, MBBS\, MPH\, MS\, DrPH is a physician and epidemiologist focused on advancing global health research\, education\, and practice. He is Professor of Nutrition\, Epidemiology\, and Global Health at Harvard T.H. Chan School of Public Health. He established and continues to lead the Nutrition and Global Health Program\, an interdepartmental initiative at Harvard where over the past 25 years he sought to strengthen the evidence base for advancing human health and development. He is an elected member of the National Academy of Medicine. \n  \n  \n \nLouise C. Ivers\, MD\, MPH\, DTM&H\, Faculty Director\, Harvard Global Health Institute \nDr. Louise C. Ivers\, MD\, MPH\, DTM&H is the Faculty Director of the Harvard Global Health Institute and the Executive Director of the Massachusetts General Hospital (MGH) Center for Global Health. Dr. Ivers is also the David Bangsberg Endowed Chair in Global Health Equity at MGH and a Professor of Medicine and Professor of Global Health and Social Medicine at Harvard Medical School. Dr. Ivers has spent her career providing care to the rural and urban poor and engaging in patient-oriented investigation that offer solutions to barriers to healthcare. She works on the design\, implementation\, and evaluation of large-scale public health programs in resource-limited settings with the goal of achieving health equity. She has worked on healthcare delivery in India\, Southeast Asia\, and Africa. From 2003-2017\, Dr. Ivers served in various leadership roles for Partners in Health\, including Clinical Director\, Chief of mission\, and Director of strategic implementation. In addition to expanding access to healthcare for the poor\, Dr. Ivers has contributed to published research articles on HIV/AIDS\, food insecurity\, and cholera treatment and prevention and is involved in global policy and advocacy.
URL:https://globalhealth.harvard.edu/event/advancing-global-adolescent-health-and-nutrition/
LOCATION:Virtual
CATEGORIES:Virtual
ATTACH;FMTTYPE=image/png:https://globalhealth.harvard.edu/wp-content/uploads/2024/10/Dr.-Fawzi-RI-Speaker-Series-Promo-Image-900-x-600px.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20241025T090000
DTEND;TZID=UTC:20241025T094500
DTSTAMP:20260818T125616
CREATED:20241001T181527Z
LAST-MODIFIED:20241112T204904Z
UID:10000824-1729846800-1729849500@globalhealth.harvard.edu
SUMMARY:Overcoming Health Inequities for Maya Populations in Guatemala
DESCRIPTION:  \nAs rural Indigenous communities face unique vulnerabilities and structural historical barriers\, innovative health care delivery models are more critical than ever. This session will explore how Maya Health Alliance has spent the past 15 years pioneering culturally and linguistically competent care in these communities. Dr. Waleska López\, Chief Medical Officer of Wuqu’ Kawoq at Maya Health Alliance\, and Dr. Peter Rohloff\, co-founder and Chief Science Officer for Maya Health Alliance and Associate Professor of Global Health and Social Medicine at Harvard\, will discuss lessons learned from their work developing a standard of excellence for engaged\, community-based care for rural indigenous communities in Guatemala. Dr. Louise Ivers will moderate the conversation.  \nOur speakers will showcase strategies for transforming lives through community-centered healthcare\, highlighting their recent efforts to address high maternal-infant morbidity and mortality\, heat-related injury in agricultural workers\, and other critical health issues faced by Guatemala’s Mayan population. This conversation will aim to inform how lessons learned in Guatemala could apply to improving the health outcomes in rural and Indigenous populations globally.    \nThis event is free and open to the public.  Please note the event will be available in both English and Spanish with translation by an interpreter through Zoom. \nRegister \nAbout the Speakers\n  \n \nDr. Peter Rohloff\, Co-founder and Chief Science Officer for Maya Health Alliance\, Associate Professor of Global Health and Social Medicine\, Associate Professor of Medicine in the Division of Global Health Equity at Brigham and Women’s Hospital  \nDr. Rohloff’s research is focused on using dissemination/implementation and quality improvement methodologies to investigate and improve barriers to health care delivery. In addition to their position at Brigham and Women’s Hospital\, they are the co-founder and Chief Science Officer for Maya Health Alliance\, a primary care organization working with indigenous Maya communities in rural Guatemala. Primary research interests include behavior change interventions for cardiovascular disease and diabetes; epidemiology of chronic kidney disease; determinants of food insecurity and chronic child malnutrition; and family-based interventions to support early child development. \n  \n \nDr. Waleska López\, Chief Medical Officer of Wuqu‘ Kawoq at Maya Health Alliance \nDr. Maxbeny Waleska López Canú is the Chief Medical Officer of Wuqu’ Kawoq at Maya Health Alliance\, overseeing a team of more than 100 healthcare workers and providing essential healthcare in indigenous languages. Dr. López \, who fled Guatemala’s civil war for refuge in Mexico as a child\, was inspired by her family’s dedication to helping refugees and pursued a career in medicine\, becoming one of the few indigenous doctors in the region. She has worked extensively in Mexico and Guatemala for Ministry of Health programs to extend coverage to rural areas.  \nDr. López is internationally recognized and has been invited to speak on subjects such as women’s leadership and health equity. She is also a co-author of several articles addressing global and indigenous health challenges. Her journey is a testament to her unwavering dedication and resilience in her mission to build a better world.  \n  \n \nDr. Louise C. Ivers\, MD\, MPH\, DTM&H\, Faculty Director\, Harvard Global Health Institute \nDr. Louise C. Ivers\, MD\, MPH\, DTM&H is the Faculty Director of the Harvard Global Health Institute and the Executive Director of the Massachusetts General Hospital (MGH) Center for Global Health. Dr. Ivers is also the David Bangsberg Endowed Chair in Global Health Equity at MGH and a Professor of Medicine and Professor of Global Health and Social Medicine at Harvard Medical School. Dr. Ivers has spent her career providing care to the rural and urban poor and engaging in patient-oriented investigation that offer solutions to barriers to healthcare. She works on the design\, implementation\, and evaluation of large-scale public health programs in resource-limited settings with the goal of achieving health equity. She has worked on healthcare delivery in India\, Southeast Asia\, and Africa. From 2003-2017\, Dr. Ivers served in various leadership roles for Partners in Health\, including Clinical Director\, Chief of mission\, and Director of strategic implementation. In addition to expanding access to healthcare for the poor\, Dr. Ivers has contributed to published research articles on HIV/AIDS\, food insecurity\, and cholera treatment and prevention and is involved in global policy and advocacy. \n  \nAbout the Global Health Coffee Sessions Event Series\nThe HGHI Coffee Sessions Virtual Series takes place on the last Friday of each month from 9:00 AM – 9:45 AM Eastern Time. Showcasing global health researchers and practitioners from Harvard and beyond\, this series aims to explore the role of partnership and collaboration when working to advance global health equity. A diverse range of topics will be covered; including climate change and health\, global health security\, mental healthcare\, reproductive healthcare access\, financing and governance for global health\, healthcare in conflict areas\, digital health\, and more. This series will take place online over Zoom\, and all sessions will be recorded and available on our YouTube Channel. \nThrough our events and programs\, the Harvard Global Health Institute provides a platform for different perspectives and debates within the field of global health through a variety of media. The views expressed in these events and programs are solely those of the speakers\, authors\, researchers\, and participating audience. As such\, they do not speak for the Institute or the university.
URL:https://globalhealth.harvard.edu/event/overcoming-health-inequities-for-maya-populations-in-guatemala/
LOCATION:Virtual
CATEGORIES:Virtual
ATTACH;FMTTYPE=image/png:https://globalhealth.harvard.edu/wp-content/uploads/2024/10/10-25-24-Coffee-Sessions-Promo-Image-900x600px-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20241015T120000
DTEND;TZID=UTC:20241015T130000
DTSTAMP:20260818T125616
CREATED:20241007T165504Z
LAST-MODIFIED:20241112T205833Z
UID:10000829-1728993600-1728997200@globalhealth.harvard.edu
SUMMARY:Arboviruses on the Rise: Mitigating the Threats from Dengue\, EEE\, Zika and More in a Changing World
DESCRIPTION:The growing threat of Dengue and other arboviruses\, such as Zika\, Chikungunya\, Yellow Fever\, and Eastern Equine Encephalitis (EEE)\, has become a critical public health concern\, particularly in tropical and sub-tropical regions\, where nearly 4 billion people are at risk\, including in the US. This webinar will convene leading experts in virology\, infectious diseases\, entomology\, and public health to discuss the rising frequency and severity of outbreaks. Panelists will explore the global spread of arboviruses\, and assess the effectiveness of current prevention and response measures\, including vector control and vaccine development. Special attention will be given to gaps in preparedness and the urgent need for coordinated international action\, particularly in the context of climate change\, urbanization\, and strained health infrastructure. \nThe event is free and open to the public. \nAbout our Speakers\n \nDr. Anoja Dheerasinghe\, MBBS\, MSc\, MD\, Medical Specialist in Public Health at the National Dengue Control Unit of the Ministry of Health\, Sri Lanka \nDr Anoja Dheerasinghe is a Medical Specialist in Public Health (Consultant Community Physician) at the National Dengue Control Unit\, Ministry of Health\, Sri Lanka. She received her MBBS from the University of Kelaniya and her Masters and Doctor of Medicine in Community Medicine from the University of Colombo\, Sri Lanka. Later\, she obtained her Master’s in Medical Entomology and Applied Parasitology from the Open University of Sri Lanka. Dr. Dheerasinghe is also a member of the Technical Advisory Group for Dengue Prevention and Control in Sri Lanka. Before her current position\, she worked as a Consultant Epidemiologist in the Epidemiology Unit in the Western Province\, Sri Lanka\, where she managed all communicable diseases\, including vector-borne diseases such as dengue\, malaria\, and filariasis. She also served as a medical doctor for the Anti-Malaria Campaign at the Ministry of Health of Sri Lanka during the pre-elimination phase. With over 25 years of experience\, she specializes in Neglected Tropical Diseases and malaria. \n  \n \nDr. Gabriela Paz-Bailey\, MD\, PhD\, MSc\, Chief of the Dengue Branch at Division of Vector Borne Diseases\, Centers for Disease Control and Prevention \nDr. Paz-Bailey is the Chief of the Dengue Brach\, Division of Vector Borne Diseases at the Centers for Disease Control and Prevention. She leads the development of research infrastructure in Puerto Rico\, to understand health disparities in the epidemiology of arboviruses and the impact of novel interventions. Dr. Paz-Bailey has done extensive work on evaluating new dengue vaccines as CDC lead for the ACIP Dengue Vaccines Workgroup. ACIP recently recommended the use of Sanofi Dengvaxia quadrivalent dengue vaccine in dengue endemic areas in the United States. This vaccine poses unique programmatic challenges to implementation in requiring pre-vaccination screening for prior dengue infection\, and messaging regarding its higher risks for dengue severe disease if dengue naives are vaccinated. Two other promising dengue candidate vaccines are in Phase Ill trials. Dr. Paz-Bailey will lead the review of the benefits and harms to present draft recommendations to ACIP. \n  \n \nDr. Amir Mohareb\, MD\, Director\, Research Program on Humanitarian Action\, Global Migration\, and Infectious Diseases at the Mass General Center for Global Health \nDr. Amir Mohareb is an Infectious Diseases physician at Massachusetts General Hospital and Harvard Medical School. His clinical and research interests center around HIV\, viral hepatitis\, tropical diseases\, and vaccine-preventable infections. His work examines the health effects of migration and forced displacement\, with the overall aim of improving clinical\, public health\, and social policies. He investigates the interaction between human-made and natural humanitarian emergencies and infectious diseases\, with an emphasis on vaccine-preventable infections. He uses epidemiology and simulation modeling to better understand how (1) complex humanitarian emergencies contribute to the risk for communicable diseases\, especially among people who are displaced\, and (2) how infectious diseases can complicate the clinical and public health response to humanitarian emergencies. \n  \nSpeakers will share their own perspectives; they do not speak for the university.
URL:https://globalhealth.harvard.edu/event/arboviruses-on-the-rise/
LOCATION:Virtual
CATEGORIES:Virtual
ATTACH;FMTTYPE=image/png:https://globalhealth.harvard.edu/wp-content/uploads/2024/10/Arbovirus-Special-Event-Promo-Image-900x600px-no-QR-Code-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20241008T120000
DTEND;TZID=America/Halifax:20241008T124500
DTSTAMP:20260818T125616
CREATED:20240910T153534Z
LAST-MODIFIED:20241112T211448Z
UID:10000819-1728388800-1728391500@globalhealth.harvard.edu
SUMMARY:Hunger\, Food Security\, and the Race to Produce New Seeds for a Climate-Changed World
DESCRIPTION:Many of the world’s most productive agricultural regions are increasingly vulnerable to extreme droughts\, floods\, and unpredictable weather patterns. As climate change forces farmers to migrate and adapt\, the ripple effects on global food systems and public health will be felt for decades. In response\, crop research centers are racing to develop new seed varieties that can withstand these harsh conditions. Drawing on lessons from the mid-twentieth century efforts to rapidly increase food production\, this session explores the urgent need for innovation in food production\, highlighting the long-term impacts on the environment\, health\, and food security. Dr. Gabriela Soto Laveaga will discuss how this race for resilience will shape the future of global health and well-being. Dr. Megan Murray will moderate the conversation. \nThe event is free and open to the public. \nAbout the Speakers\n \nGabriela Soto Laveaga\, PhD\, MA\, Professor of the History of Science and Antonio Madero Professor for the Study of Mexico at Harvard University \nGabriela Soto Laveaga is Professor of the History of Science and Antonio Madero Professor for the Study of Mexico at Harvard University. Her award-winning first book Jungle Laboratories: Mexican Peasants\, National Projects and the Making of the Pill narrated the impact of the search for medicinal plants at the local\, national\, and global level. Her award-wining articles have ranged from examining the role of indigenous midwives in the Mexican healthcare system\, the use of soap operas to deliver public health messaging\, Latin American innovation in science and medicine\, and how we narrate histories of science outside of so-called centers of innovation. She is completing two book manuscripts: one on doctors as agents of social unrest and her third book which examines agricultural science exchange between India and Mexico. She has been a fellow at the Institute of Advanced Study at Princeton\, held the Dibner Distinguished fellowship in History of Science and Technology at the Huntington Library\, among other awards. Most recently she was elected to the Academia Mexicana de la Historia\, one of the highest honors for a historian of Mexico\, especially one outside of the country. She is also a past recipient of the Everett Mendelsohn Excellence in Graduate Mentoring Award. \n  \n \nMegan Murray\, ScD\, MD\, Ronda Stryker and William Johnston Professor of Global Health\, Harvard Medical School; Director of Research\, Global Health & Social Medicine\, Harvard Medical School \nMegan Murray is an epidemiologist and an infectious disease physician\, with over 25 years of experience studying tuberculosis and other infectious diseases. She received her MD from Harvard Medical School in 1990 and completed her residency in internal medicine and a fellowship in Infectious Disease at Massachusetts General Hospital. She received her ScD in Epidemiology from the Harvard School of Public Health in 2000. She currently serves as the Ronda Stryker and William Johnston Professor of Global Health and Social Medicine at Harvard Medical School and as a Professor of Epidemiology at the Harvard Chan School of Public Health. \nDr. Murray’s research focuses on social\, host and pathogen specific determinants of TB infection\, disease and treatment outcomes. She studies nutritional risk factors for TB infection and disease\, including macronutrients status and the role of Vitamins A\, E and D. She uses bacterial and human genetic and genomic tools to identify variants of interest and their role in TB. \n  \nAbout the Global Research and Innovation Speaker Series\nThe Harvard Global Health Institute’s Global Health Research and Innovation Speaker Series showcases the latest scholarly and scientific advancements in global health across Harvard and beyond\, to make cutting-edge research accessible to a diverse global audience\, and to spark innovative solutions in the pursuit of health equity and improved health outcomes worldwide. The public series takes place virtually on the second Tuesday of each month from 12:00 to 12:45 pm ET. Each session will include a presentation by a featured speaker showcasing their innovative research in global health\, followed by a moderated Q&A. \nSpeakers will share their own perspectives; they do not speak for Harvard.
URL:https://globalhealth.harvard.edu/event/hunger-food-security-and-the-race-to-produce-new-seeds/
LOCATION:Virtual
CATEGORIES:Virtual
ATTACH;FMTTYPE=image/png:https://globalhealth.harvard.edu/wp-content/uploads/2024/09/Soto-RI-Speaker-Series-Mailchimp-Image-Template-900-x-600px.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20240927T090000
DTEND;TZID=UTC:20240927T094500
DTSTAMP:20260818T125616
CREATED:20240912T183259Z
LAST-MODIFIED:20241001T170814Z
UID:10000820-1727427600-1727430300@globalhealth.harvard.edu
SUMMARY:Forging Bidirectional Accompaniment in Global Health
DESCRIPTION:Join us for an insightful conversation on the concept of bidirectional accompaniment in global health with Dr. Joia Mukherjee\, Director of the Master of Medical Sciences in Global Health Delivery program and Global Medical Education and Social Change program at Harvard Medical School and Chief Medical Officer at Partners In Health alongside Dr. Anatole Manzi\, Deputy Chief Medical Officer of Learning and Quality Health Systems Strengthening at Partners in Health. This session will delve into the profound definition of accompaniment as articulated by Paul Farmer: “Being present on a journey with someone and committing to that person’s well-being.  Accompaniment is both an objective that is set at the beginning of a task and a mode of follow through.”  \nDrs. Mukherjee and Manzi will illustrate how bidirectional accompaniment is a cornerstone of success in global health practice\, where sharing new skills\, tools\, and approaches is not an optional endeavor\, but a crucial element. The pair will provide concrete examples of how this concept plays out in global health\, defining exactly what it looks like as well as what it does not. Dr. Louise Ivers\, Faculty Director of the Harvard Global Health Institute\, will moderate the discussion. \nThe event is free and open to the public. \nRegister \nAbout the Speakers\n \nJoia S. Mukherjee\, MD\, MPH\, Chief Medical Officer\, Partners In Health\, Director and Advisory Dean\, F.W. Peabody Society\, Director\, Master in Medical Science in Global Health Delivery\, Harvard Medical School; Associate Professor of Medicine\, Brigham and Women’s Hospital \nDr. Mukherjee is an associate professor of medicine in the Division of Global Health Equity\, Department of Medicine\, Brigham and Women’s Hospital\, and associate professor of global health and social medicine at Harvard Medical School. She directs the Master of Medical Sciences in Global Health Delivery program and the Program in Global Medical Education and Social Change. She teaches infectious disease\, global health delivery\, and human rights to health professionals and students from around the world. Dr. Mukherjee has helped to create new residency and fellowship training programs for Rwandan and Haitian physicians as well as global health residencies and fellowships for US trainees at Harvard and other American universities. \nDr. Mukherjee’s scholarly work focuses on the provision of health as a human right and on the design\, implementation\, and evaluation of comprehensive health care in resource-poor settings. \nDr. Mukherjee is a graduate of the University of Minnesota Medical School\, trained in infectious disease\, internal medicine\, and pediatrics at the Massachusetts General Hospital\, and has an MPH from the Harvard School of Public Health. Since 2000\, Dr. Mukherjee has served as the chief medical officer of Partners In Health\, a nonprofit medical organization focused on reducing global health disparities by strengthening health systems through public sector support and community-based programs. She provides strategic guidance on the implementation of clinical programs at PIH’s sites in Haiti\, Rwanda\, Malawi\, Lesotho\, Peru\, Mexico\, Russia\, Sierra Leone\, and Liberia and has served as an expert consultant for the World Health Organization and Ministries of Health of HIV\, TB\, health systems strengthening and health workforce development. \n  \nDr. Mukherjee also serves on the board of directors for Village Health Works (Burundi) and Muso (Mali) and the Institute for Justice and Democracy in Haiti. She advises various grassroots organizations throughout the developing world in their work to deliver health care with a human rights-based approach to the poorest of the poor. \n  \n \nAnatole Manzi\, PhD\, MPhil\, MPH\, Deputy Chief Medical Officer\, Learning and Quality Health Systems Strengthening\, Partners in Health \nAnatole Manzi serves as the Deputy Chief Medical Officer at Partners In Health (PIH)\, where he oversees learning and quality health systems strengthening. In this role\, Dr. Manzi collaborates with PIH-supported countries to develop and implement strategies for quality improvement and health systems strengthening. His work focuses on integrating quality management with clinical practice through innovative solutions. Additionally\, he manages relationships with various partners\, including academic and non-academic global health organizations\, to support the design\, implementation\, evaluation\, and dissemination of best practices in patient safety and systems improvement. \nPreviously\, Dr. Manzi held the positions of Director of Clinical Practice and Quality Improvement and Director of Global Learning and Training at PIH. In these roles\, he led the organization-wide education and training strategy\, including the development and standardization of guidelines and tools essential for delivering high-quality care in PIH-supported countries. He also designed and directed the Mentorship\, Enhanced Supervision for Healthcare and Quality Improvement (MESH-QI) program\, an innovative health systems strengthening approach that significantly improved core clinical domains such as maternal and newborn health\, infectious diseases\, and non-communicable diseases. \nDr. Manzi has served on various technical working groups at the World Health Organization (WHO) and the Rwandan Ministry of Health. As an implementation scientist\, his research focuses on developing\, adapting\, and validating healthcare quality measurement and improvement metrics in resource-limited settings. He is an Assistant Professor at the University of Global Health Equity and a Lecturer at Harvard Medical School. \n  \n \nLouise C. Ivers\, MD\, MPH\, DTM&H\, Faculty Director\, Harvard Global Health Institute \nDr. Louise C. Ivers\, MD\, MPH\, DTM&H is the Faculty Director of the Harvard Global Health Institute and the Executive Director of the Massachusetts General Hospital (MGH) Center for Global Health. Dr. Ivers is also the David Bangsberg Endowed Chair in Global Health Equity at MGH and a Professor of Medicine and Professor of Global Health and Social Medicine at Harvard Medical School. Dr. Ivers has spent her career providing care to the rural and urban poor and engaging in patient-oriented investigation that offer solutions to barriers to healthcare. She works on the design\, implementation\, and evaluation of large-scale public health programs in resource-limited settings with the goal of achieving health equity. She has worked on healthcare delivery in India\, Southeast Asia\, and Africa. From 2003-2017\, Dr. Ivers served in various leadership roles for Partners in Health\, including Clinical Director\, Chief of mission\, and Director of strategic implementation. In addition to expanding access to healthcare for the poor\, Dr. Ivers has contributed to published research articles on HIV/AIDS\, food insecurity\, and cholera treatment and prevention and is involved in global policy and advocacy. \nAbout the Global Health Coffee Sessions Event Series\nThe HGHI Coffee Sessions Virtual Series takes place on the last Friday of each month from 9:00 AM – 9:45 AM Eastern Time. Showcasing global health researchers and practitioners from Harvard and beyond\, this series aims to explore the role of partnership and collaboration when working to advance global health equity. A diverse range of topics will be covered; including climate change and health\, global health security\, mental healthcare\, reproductive healthcare access\, financing and governance for global health\, healthcare in conflict areas\, digital health\, and more. This series will take place online over Zoom\, and all sessions will be recorded and available on our YouTube Channel. \nThrough our events and programs\, the Harvard Global Health Institute provides a platform for different perspectives and debates within the field of global health through a variety of media. The views expressed in these events and programs are solely those of the speakers\, authors\, researchers\, and participating audience. As such\, they do not speak for the Institute or the university.
URL:https://globalhealth.harvard.edu/event/forging-bidirectional-accompaniment-in-global-health/
LOCATION:Virtual
CATEGORIES:Virtual
ATTACH;FMTTYPE=image/png:https://globalhealth.harvard.edu/wp-content/uploads/2024/09/9-27-24-Coffee-Sessions-Mailchimp-Image-900x600px.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20240910T120000
DTEND;TZID=America/Halifax:20240910T124500
DTSTAMP:20260818T125616
CREATED:20240827T142350Z
LAST-MODIFIED:20240828T150140Z
UID:10000249-1725969600-1725972300@globalhealth.harvard.edu
SUMMARY:Impact of Arbovirus Infection on Pregnancy
DESCRIPTION:  \n \nThe adverse impact of Zika (ZIKV)\, dengue (DENV)\, and chikungunya (CHIKV) virus infection in pregnancy has been recognized in Latin America and Asia but is not well studied in Africa. Although originally discovered in sub-Saharan Africa\, the non-specific clinical presentation of arbovirus infection may have hampered our detection of adverse clinical outcomes and outbreaks. This prospective study of arbovirus infection in pregnant women in north-central Nigeria sought to characterize the prevalence of acute arbovirus infection and determine the impact on pregnancy and infant outcomes. \nDr. Phyllis Kanki will talk about her research on this important topic and attendees are encouraged to join the discussion by sending us their questions. Dr. Louise Ivers will moderate the conversation. \nThe event is free and open to the public. \nAbout the Speakers\n\nPhyllis Kanki\, DVM\, DSc\, Mary Woodard Lasker Professor of Health Sciences \nPhyllis Kanki is the Mary Woodard Lasker Professor of Health Sciences at the Harvard T. H. Chan School of Public Health. She has worked in West Africa since 1984\, where her research in Senegal provided the initial characterization of HIV-2\, demonstrated reduced virulence\, transmission and progression to disease and interactions with HIV-1 subtypes. In 2000\, she founded the AIDS Prevention Initiative in Nigeria (APIN)\, supported by the Bill & Melinda Gates Foundation modeled after the Senegal research collaboration. She led Harvard’s President’s Emergency Plan for AIDS Relief (PEPFAR) program supporting prevention\, care and HIV antiretroviral therapy for over 200\,000 patients in Nigeria\, Botswana\, and Tanzania (2005-2013). In West Africa\, following epidemics of Ebola (EBOV) and Zika virus (ZIKV)\, she documented the multi-decade presence of ZIKV\, demonstrating the endemicity of this unique arbovirus in the region. She described the longevity\, specificity and cross reactivity of T cell responses to ZIKV and DENV and characterized the T cell responses in survivors and exposed health care workers from the 2015 Nigeria EBOV outbreak. She has just completed a 3 year study of ZIKV\, dengue and Chikungunya virus infection in pregnant women and documenting associated microcephaly and other birth abnormalities. \n  \n \nLouise C. Ivers\, MD\, MPH\, DTM&H\, Faculty Director\, Harvard Global Health Institute \nDr. Louise C. Ivers\, MD\, MPH\, DTM&H is the Faculty Director of the Harvard Global Health Institute and the Executive Director of the Massachusetts General Hospital (MGH) Center for Global Health. Dr. Ivers is also the David Bangsberg Endowed Chair in Global Health Equity at MGH and a Professor of Medicine and Professor of Global Health and Social Medicine at Harvard Medical School. Dr. Ivers has spent her career providing care to the rural and urban poor and engaging in patient-oriented investigation that offer solutions to barriers to healthcare. She works on the design\, implementation\, and evaluation of large-scale public health programs in resource-limited settings with the goal of achieving health equity. She has worked on healthcare delivery in India\, Southeast Asia\, and Africa. From 2003-2017\, Dr. Ivers served in various leadership roles for Partners in Health\, including Clinical Director\, Chief of mission\, and Director of strategic implementation. In addition to expanding access to healthcare for the poor\, Dr. Ivers has contributed to published research articles on HIV/AIDS\, food insecurity\, and cholera treatment and prevention and is involved in global policy and advocacy.
URL:https://globalhealth.harvard.edu/event/research-and-innovation-speaker-series-2024-09-10/
LOCATION:Virtual
CATEGORIES:Virtual
ATTACH;FMTTYPE=image/png:https://globalhealth.harvard.edu/wp-content/uploads/2024/08/Phyllis-Kanki-RI-Speaker-Series-Promo-Image-900-x-600-px.png
END:VEVENT
END:VCALENDAR